Skip to main content

Month: September 2023

Check Point to Acquire Atmosec, an Innovative SaaS Security Vendor, as part of its Strategy to Deliver the Most Secure SASE Solution

The technology will allow organizations to prevent cyberattacks on their SaaS ecosystem: discover and disconnect malicious applications, prevent communication with risky 3rd party applications and fix SaaS misconfigurations SAN CARLOS, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) —  Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of cyber security solutions globally, has announced the acquisition of Atmosec. An early-stage start-up, Atmosec specializes in the rapid discovery and disconnection of malicious SaaS applications, preventing risky 3rd party SaaS communications, and rectifying SaaS misconfigurations. The move reinforces Check Point‘s commitment to enhance its SaaS security offering and address the security gaps and blind spots in SaaS applications. Atmosec was founded in January 2021 and employs 17...

Continue reading

VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC

Merger with Notable expected to close in mid-October, subject to shareholder approval Special shareholder meeting scheduled for October 12, 2023 MODI’IN, Israel and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today announced that its registration statement on Form S-4 in connection with the proposed merger with Notable Labs, Inc. (“Notable”) has been declared effective by the U.S. Securities and Exchange Commission (“SEC”). The definitive merger agreement between VBL and Notable was announced on February 23, 2023 and is expected to close in mid-October 2023, subject to customary closing conditions, including approval of the merger by VBL’s shareholders. The registration statement contains a proxy statement / prospectus / information statement in connection with the merger.  A copy of the...

Continue reading

Whitestone REIT Declares Fourth Quarter 2023 Dividend

HOUSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced that its Board of Trustees has declared a monthly cash dividend of $0.04 per share on the Company’s common shares and operating partnership units for the fourth quarter of 2023. The dividend increase represents a quarterly amount of $0.12 per share, and an annualized amount of $0.48 per share. “At Whitestone, we are successfully executing on our growth strategy and continue to drive very strong leasing spreads while posting near-record occupancy, as we shared during our 2nd quarter earnings call,” said Dave Holeman, Whitestone’s CEO. “We remain focused on FFO per share growth and simultaneously strengthening our balance sheet.” The fourth quarter dividend distribution for 2023 will be as detailed below:Month Record...

Continue reading

Regency Centers to Present at the BofA Securities 2023 Global Real Estate Conference

JACKSONVILLE, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency” or the “Company”) (Nasdaq: REG) today announced that Mike Mas, Executive Vice President and Chief Financial Officer, is scheduled to make a presentation at the 2023 BofA Securities 2023 Global Real Estate Conference (the “Conference”) on Wednesday, September 13, 2023, at 2:10 pm ET. To access the Company’s live presentation, use the webcast registration link below.Regency Centers PresentationDate: Wednesday, September 13, 2023Time: 2:10 p.m. – 2:45 p.m. ETSpeakers: Mike Mas – Executive Vice President & Chief Financial OfficerChristy McElroy – Senior Vice President, Capital MarketsWebcast Link: Regency Centers BofA Securities 2023 Global Real Estate Conference   A replay of the webcast will be available on the Company’s...

Continue reading

Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

HANOVER, MD, Sept. 06, 2023 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that Chief Executive Officer George Ng will present a corporate overview at the at the H.C. Wainwright 25th Annual Global Investment Conference. The conference is being held on September 11 – 13, 2023 at the Lotte New York Palace Hotel. Presentation Date: September 13, 2023 Time: 3:30pm ET Webcast Link: https://journey.ct.events/view/ce209a76-e148-4890-bd72-de6478b6e5f6 Mr. Ng and Chief Financial Officer James Stanker will be available for one-on-one meetings throughout the conference. Investors can attend the conference...

Continue reading

Indaptus Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 25th Annual Global Investment Conference. The conference is being held on September 11 – 13, 2023 at the Lotte New York Palace Hotel.Presentation Date: September 13, 2023   Time: 8:30am ET Webcast Link:   https://journey.ct.events/view/a2bb617e-99c0-4e6c-8b4a-15d80a10a66f A live webcast of the presentation can be accessed on the investor relations section of the Indaptus website. A replay of the webcast will be archived and available following the event for approximately 90 days. https://indaptusrx.com/investors/events-presentations/ Mr. Meckler will be available for one-on-one meetings throughout...

Continue reading

MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing

ROCKVILLE, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced the appointment of Ali Soleymannezhad as Executive Vice President of Bioprocessing, effective August 21, 2023. Mr. Soleymannezhad will lead global product development and marketing strategy for MaxCyte’s bioprocessing business. The bioprocessing business is anchored by the STx and VLx platforms supporting biotherapeutic research, development and manufacturing using transient expression to produce complex proteins, vaccines and biologics at scale. “With his commercial background, strategic insight...

Continue reading

Spero Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference

CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Sath Shukla, President and Chief Executive Officer of Spero Therapeutics, will present and be available for one-on-one meetings at the H.C. Wainwright 25th Annual Global Investment Conference, which is taking place September 11-13, 2023, at the Lotte New York Palace Hotel in New York, NY. Details are as follows: H.C. Wainwright 25th Annual Global Investment Conference Corporate Presentation: Tuesday, September 12, 2023, from 11:30 AM-12:00 PM ET Webcast Link: https://journey.ct.events/view/7d04fb43-ff26-406f-9676-dc4aa23e674d The...

Continue reading

Watsco Acquires Gateway Supply Company

$180 Million Distributor Adds 16 Locations in Core Sunbelt MarketsGateway Builds on Watsco’s Leading Scale in Fragmented $50 Billion HVAC Marketplace MIAMI, Sept. 06, 2023 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced that it has completed the acquisition of Gateway Supply Company, Inc., a distributor of plumbing and HVAC products. Founded in Columbia, South Carolina in 1964, Gateway Supply has annual sales of approximately $180 million and serves approximately 4,000 customers from 15 locations in South Carolina and one location in North Carolina. The company distributes approximately 40,000 SKUs from more than 600 vendors. Albert H. Nahmad, Watsco’s Chairman and Chief Executive Officer, commented: “We are pleased to welcome Gateway to the Watsco family. We have deep admiration for the company’s culture and impressive...

Continue reading

Daktronics, Inc. Announces 2024 Fiscal First Quarter Results

BROOKINGS, S.D., Sept. 06, 2023 (GLOBE NEWSWIRE) — Daktronics, Inc. (NASDAQ – DAKT) today reported results for its fiscal 2024 first quarter which ended July 29, 2023. Q1 FY2024 financial highlights:Record first quarter net sales of $232.5 million, a 35.3 percent increase from the first quarter of fiscal 2023 Gross profit as a percentage of net sales of 30.6 percent as a result of record sales volume, stable operations and prior strategic pricing actions Operating income rebounded to $40.2 million as compared to an operating loss of $5.5 million in the first quarter of fiscal 2023 Product order backlog was $323.7 million(1) at July 29, 2023 compared to $400.7 million at the end of the fourth quarter of fiscal 2023 and $469.1 million in the year-earlier period. This change reflects a more stable operating environment and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.